CH625123A5 - - Google Patents

Download PDF

Info

Publication number
CH625123A5
CH625123A5 CH1543576A CH1543576A CH625123A5 CH 625123 A5 CH625123 A5 CH 625123A5 CH 1543576 A CH1543576 A CH 1543576A CH 1543576 A CH1543576 A CH 1543576A CH 625123 A5 CH625123 A5 CH 625123A5
Authority
CH
Switzerland
Prior art keywords
solution
injection
potassium
ready
water
Prior art date
Application number
CH1543576A
Other languages
German (de)
English (en)
Inventor
Heinrich Dr Rer Nat Woog
Werner Gruber
Werner Dr Rer Nat Rothe
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of CH625123A5 publication Critical patent/CH625123A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CH1543576A 1975-12-12 1976-12-08 CH625123A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2556001A DE2556001C3 (de) 1975-12-12 1975-12-12 Spritzfertige injizierbare Lösungen mit einem Gehalt an Alkalicanrenoat

Publications (1)

Publication Number Publication Date
CH625123A5 true CH625123A5 (xx) 1981-09-15

Family

ID=5964213

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1543576A CH625123A5 (xx) 1975-12-12 1976-12-08

Country Status (13)

Country Link
US (1) US4088759A (xx)
JP (1) JPS5272811A (xx)
AT (1) AT345465B (xx)
BE (1) BE849282A (xx)
CA (1) CA1062157A (xx)
CH (1) CH625123A5 (xx)
DE (1) DE2556001C3 (xx)
DK (1) DK153441C (xx)
FI (1) FI55442C (xx)
FR (1) FR2334371A1 (xx)
GB (1) GB1509477A (xx)
NL (1) NL187517C (xx)
SE (1) SE442587B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950832C2 (de) * 1979-12-18 1983-03-17 Hoechst Ag, 6000 Frankfurt Spritzfertige injizierbare wäßrige Lösungen der Alkalisalze von Canrenoinsäure und Furosemid
JPS5913257A (ja) * 1982-07-14 1984-01-24 Matsushita Electric Ind Co Ltd 自動原稿送り装置
DE4228926A1 (de) * 1992-08-31 1994-03-03 Boehringer Mannheim Gmbh Spritzfertige Azosemid-Injektionslösungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3276959A (en) * 1963-08-08 1966-10-04 Hefa G M B H Stabilized steroid compositions
US3487152A (en) * 1967-02-07 1969-12-30 Hoffmann La Roche Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances
DE2423550A1 (de) * 1974-05-15 1975-11-27 Boehringer Mannheim Gmbh Pharmazeutisches praeparat

Also Published As

Publication number Publication date
SE7613849L (sv) 1977-06-13
BE849282A (fr) 1977-06-10
FI55442B (fi) 1979-04-30
ATA916376A (de) 1978-01-15
CA1062157A (en) 1979-09-11
FR2334371B1 (xx) 1980-03-28
DK153441C (da) 1988-11-21
NL7613750A (nl) 1977-06-14
FR2334371A1 (fr) 1977-07-08
FI55442C (fi) 1979-08-10
JPS5272811A (en) 1977-06-17
US4088759A (en) 1978-05-09
SE442587B (sv) 1986-01-20
GB1509477A (en) 1978-05-04
DE2556001B2 (de) 1979-04-12
AU2043776A (en) 1977-10-20
DK153441B (da) 1988-07-18
AT345465B (de) 1978-09-25
DE2556001A1 (de) 1977-06-16
NL187517C (nl) 1991-11-01
JPS5517010B2 (xx) 1980-05-08
DE2556001C3 (de) 1979-11-29
FI763564A (xx) 1977-06-13
NL187517B (nl) 1991-06-03
DK547176A (da) 1977-06-13

Similar Documents

Publication Publication Date Title
DE69305642T2 (de) Injizierbares Arzneimittel und Satz, die Omoprazol oder verwandte Verbindungenenthalten
DE4344824C1 (de) Hochkonzentriertes Immunglobulin-Präparat und Verfahren zu seiner Herstellung
DE69104724T2 (de) Florfenicol enthaltendes arzneimittel.
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
DE69827357T2 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DE3042332A1 (de) Waessrige nitroglycerinloesung
DE2827027B2 (de) Gefriergetrocknetes natives T -globulin-Präparat zur intravenösen Verabreichung
EP0253226A1 (de) Spritzfertige, wässrige, alkalische Injektionslösung von Torasemid und Verfahren zu ihrer Herstellung
DE4010536C2 (xx)
CH625123A5 (xx)
DE1053736B (de) Verfahren zur Erhoehung der Loeslichkeit therapeutisch wirksamer Stoffe in Wasser
DE60101979T2 (de) Lösung enthaltend N-[O-(p-pivaloyloxybenzenesulfonylamino)benzoyl]glyzin Mononatriumsalz Tetrahydrat und diese Lösung enthaltendes Arzneimittel
DE2546474A1 (de) Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
DE1792448C3 (de) Verfahren zur Herstellung von zur parenteralen Verabreichung geeigneten stabilen Lösungen von therapeutisch anwendbaren Benzodiazepinderivaten
DE938502C (de) Verfahren zur Herstellung einer kolloidalen Eisenzubereitung
DE3509741A1 (de) Orale dosierungsform von etoposid
EP0108248B2 (de) Lösungsvermittlerfreie, wässrige Nitroglycerinlösung
EP0656777B1 (de) Spritzfertige azosemid-injektionslösungen
DE2209526A1 (de) Coronarmittel in spezieller form sowie verfahren zu seiner herstellung
DE2820992A1 (de) Arzneimittel auf nitroimidazol-basis
DE1617433C (de) Verfahren zur Herstellung von 5,5 Diphenyl hydantoin Natrium Losungen fur Injektionszwecke
DE2538678A1 (de) Injizierbare loesungen
DE2445401C3 (de) Injizierbare, einphasige Zubereitung und Verfahren zu ihrer Herstellung
DE863985C (de) Verfahren zur Herstellung von Penicillinzubereitungen
DE2026864C (de) 2-Äthyl- oder 2-Propylthioisonikotinsäureamid enthaltende InjektionsJösungen

Legal Events

Date Code Title Description
PL Patent ceased